| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Avalon Ventures Xi, L.P. is a 10% Owner at Janux Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 47 sells.
Estimated insider holdings value: $37.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | JANX Janux Therapeutics, Inc. | 10% Owner | Sale+OE | 1,673,128 | $46.30 | $77,472,371.23 | -5.6% | -18.8% | -46.5% | |
| Sep 30, 2024 | JANX Janux Therapeutics, Inc. | 10% Owner | Sale+OE | 307,779 | $46.96 | $14,452,393.76 | -1.2% | +15.6% | -46.2% | |
| Sep 12, 2024 | JANX Janux Therapeutics, Inc. | - | Sell | 451,091 | $46.89 | $21,153,619.49 | -2.2% | +36.4% | -48.3% | |
| Sep 9, 2024 | JANX Janux Therapeutics, Inc. | - | Sale+OE | 242,182 | $42.00 | $10,172,364.06 | -3.3% | +47.3% | -43.2% | |
| Jun 3, 2024 | JANX Janux Therapeutics, Inc. | 10% Owner | Sell | 1,500,000 | $54.75 | $82,125,000.00 | -17.2% | -18.1% | -53.7% | |
| Nov 13, 2023 | JANX Janux Therapeutics, Inc. | 10% Owner | Buy | 849,854 | $5.87 | $4,988,642.98 | New | +21.4% | +645.3% | |
| Jun 15, 2021 | JANX Janux Therapeutics, Inc. | 10% Owner | Buy | 629,411 | $17.00 | $10,699,987.00 | +16.3% | +52.6% | -37.6% |